Prescription drug · ANDA
Mefenamic Acid NDC 0276-0509
Mefenamic acid 250 mg/1 · Capsule · Oral · Misemer Pharmaceuticals, Inc
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0276-0509-30 | 00276050930 | 30 CAPSULE in 1 BOTTLE (0276-0509-30)Marketed from Nov 1, 2021 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Mefenamic Acid
- Generic name (nonproprietary)
- mefenamic acid
- Active ingredients
- Mefenamic acid — 250 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- Misemer Pharmaceuticals, Inc
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 091608
- Marketing start
- Listing expires
- Other FDA classes
- Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)
- Identifiers
- Product ID 0276-0509_4bc27dd6-5112-b6c1-e063-6394a90a5ed4SPL ID 4bc27dd6-5112-b6c1-e063-6394a90a5ed4SPL set ID d0291319-ab3e-20c8-e053-2a95a90afabbRxCUI 829500UNII 367589PJ2C
- Pharmacologic class
- Nonsteroidal Anti-inflammatory Drug
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400276050930followed by a unit qualifier and the quantityPackage 00276-0509-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE Carefully consider the potential benefits and risks of mefenamic acid and other treatment options before deciding to use mefenamic acid. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals ( see WARNINGS ). Mefenamic acid is indicated: For relief of mild to moderate pain in patients ≥14 years of age, when therapy will not exceed one week (7 days). For treatment of primary dysmenorrhea.
Excerpt only. Read the full label for complete information.